Cargando…
Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital
BACKGROUND: Procalcitonin (PCT) is a useful marker for pneumonia. However, its clinical usefulness in elderly patients has not been studied extensively. This study aimed to assess the relationship between PCT and prognosis and pneumonia severity in elderly patients with pneumonia acquired outside th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323702/ https://www.ncbi.nlm.nih.gov/pubmed/30616612 http://dx.doi.org/10.1186/s12877-018-1008-8 |
_version_ | 1783385817439272960 |
---|---|
author | Akagi, Takanori Nagata, Nobuhiko Miyazaki, Hiroyuki Harada, Taishi Takeda, Satoshi Yoshida, Yuji Wada, Kenji Fujita, Masaki Watanabe, Kentaro |
author_facet | Akagi, Takanori Nagata, Nobuhiko Miyazaki, Hiroyuki Harada, Taishi Takeda, Satoshi Yoshida, Yuji Wada, Kenji Fujita, Masaki Watanabe, Kentaro |
author_sort | Akagi, Takanori |
collection | PubMed |
description | BACKGROUND: Procalcitonin (PCT) is a useful marker for pneumonia. However, its clinical usefulness in elderly patients has not been studied extensively. This study aimed to assess the relationship between PCT and prognosis and pneumonia severity in elderly patients with pneumonia acquired outside the hospital. METHODS: Data considered relevant to pneumonia severity and prognosis were retrospectively obtained from clinical charts of all patients with pneumonia who were admitted to our hospital from 2010 to 2017. The primary outcome was 30-day mortality in elderly patients (aged ≥75 years), and the relationship between PCT levels and pneumonia severity, as determined by the pneumonia severity index (PSI) was also examined. RESULTS: Data were collected from 667 patients, of which 436 were elderly patients. Multivariate and receiver operating characteristic curve analysis revealed that albumin, body mass index, and PSI class rather than PCT are important factors related to 30-day mortality in elderly patients. PCT was also not an independent prognostic factor in younger patients. PCT levels significantly differed by pneumonia severity (mild, moderate, and severe) in both younger (p < 0.001) and elderly (p < 0.0001) patients, with levels increasing as severity increased. In contrast, C-reactive protein (CRP) levels and white blood cell counts did not significantly differ by pneumonia severity in younger and elderly patients. A subgroup analysis focused on Streptococcus pneumoniae pneumonia revealed that PCT levels differed by severity in elderly patients (p = 0.03), with levels increasing as severity increased. CONCLUSION: PCT was not an independent predictor of 30-day mortality in both of elderly and younger patients. PCT levels, but not CRP levels, significantly increased with increasing pneumonia severity in younger and elderly patients, although the degree of increase tended to be lower in elderly patients compared to younger patients for the same severity. PCT levels also significantly increased with increasing pneumonia severity in elderly patients with Streptococcus pneumoniae pneumonia. |
format | Online Article Text |
id | pubmed-6323702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63237022019-01-10 Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital Akagi, Takanori Nagata, Nobuhiko Miyazaki, Hiroyuki Harada, Taishi Takeda, Satoshi Yoshida, Yuji Wada, Kenji Fujita, Masaki Watanabe, Kentaro BMC Geriatr Research Article BACKGROUND: Procalcitonin (PCT) is a useful marker for pneumonia. However, its clinical usefulness in elderly patients has not been studied extensively. This study aimed to assess the relationship between PCT and prognosis and pneumonia severity in elderly patients with pneumonia acquired outside the hospital. METHODS: Data considered relevant to pneumonia severity and prognosis were retrospectively obtained from clinical charts of all patients with pneumonia who were admitted to our hospital from 2010 to 2017. The primary outcome was 30-day mortality in elderly patients (aged ≥75 years), and the relationship between PCT levels and pneumonia severity, as determined by the pneumonia severity index (PSI) was also examined. RESULTS: Data were collected from 667 patients, of which 436 were elderly patients. Multivariate and receiver operating characteristic curve analysis revealed that albumin, body mass index, and PSI class rather than PCT are important factors related to 30-day mortality in elderly patients. PCT was also not an independent prognostic factor in younger patients. PCT levels significantly differed by pneumonia severity (mild, moderate, and severe) in both younger (p < 0.001) and elderly (p < 0.0001) patients, with levels increasing as severity increased. In contrast, C-reactive protein (CRP) levels and white blood cell counts did not significantly differ by pneumonia severity in younger and elderly patients. A subgroup analysis focused on Streptococcus pneumoniae pneumonia revealed that PCT levels differed by severity in elderly patients (p = 0.03), with levels increasing as severity increased. CONCLUSION: PCT was not an independent predictor of 30-day mortality in both of elderly and younger patients. PCT levels, but not CRP levels, significantly increased with increasing pneumonia severity in younger and elderly patients, although the degree of increase tended to be lower in elderly patients compared to younger patients for the same severity. PCT levels also significantly increased with increasing pneumonia severity in elderly patients with Streptococcus pneumoniae pneumonia. BioMed Central 2019-01-07 /pmc/articles/PMC6323702/ /pubmed/30616612 http://dx.doi.org/10.1186/s12877-018-1008-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Akagi, Takanori Nagata, Nobuhiko Miyazaki, Hiroyuki Harada, Taishi Takeda, Satoshi Yoshida, Yuji Wada, Kenji Fujita, Masaki Watanabe, Kentaro Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital |
title | Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital |
title_full | Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital |
title_fullStr | Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital |
title_full_unstemmed | Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital |
title_short | Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital |
title_sort | procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323702/ https://www.ncbi.nlm.nih.gov/pubmed/30616612 http://dx.doi.org/10.1186/s12877-018-1008-8 |
work_keys_str_mv | AT akagitakanori procalcitoninisnotanindependentpredictorof30daymortalityalbeitpredictspneumoniaseverityinpatientswithpneumoniaacquiredoutsidethehospital AT nagatanobuhiko procalcitoninisnotanindependentpredictorof30daymortalityalbeitpredictspneumoniaseverityinpatientswithpneumoniaacquiredoutsidethehospital AT miyazakihiroyuki procalcitoninisnotanindependentpredictorof30daymortalityalbeitpredictspneumoniaseverityinpatientswithpneumoniaacquiredoutsidethehospital AT haradataishi procalcitoninisnotanindependentpredictorof30daymortalityalbeitpredictspneumoniaseverityinpatientswithpneumoniaacquiredoutsidethehospital AT takedasatoshi procalcitoninisnotanindependentpredictorof30daymortalityalbeitpredictspneumoniaseverityinpatientswithpneumoniaacquiredoutsidethehospital AT yoshidayuji procalcitoninisnotanindependentpredictorof30daymortalityalbeitpredictspneumoniaseverityinpatientswithpneumoniaacquiredoutsidethehospital AT wadakenji procalcitoninisnotanindependentpredictorof30daymortalityalbeitpredictspneumoniaseverityinpatientswithpneumoniaacquiredoutsidethehospital AT fujitamasaki procalcitoninisnotanindependentpredictorof30daymortalityalbeitpredictspneumoniaseverityinpatientswithpneumoniaacquiredoutsidethehospital AT watanabekentaro procalcitoninisnotanindependentpredictorof30daymortalityalbeitpredictspneumoniaseverityinpatientswithpneumoniaacquiredoutsidethehospital |